KR900700103A - 항-알레르기성 점안제 - Google Patents

항-알레르기성 점안제

Info

Publication number
KR900700103A
KR900700103A KR1019890701510A KR890701510A KR900700103A KR 900700103 A KR900700103 A KR 900700103A KR 1019890701510 A KR1019890701510 A KR 1019890701510A KR 890701510 A KR890701510 A KR 890701510A KR 900700103 A KR900700103 A KR 900700103A
Authority
KR
South Korea
Prior art keywords
eye drop
added
drop according
eye drops
salt
Prior art date
Application number
KR1019890701510A
Other languages
English (en)
Other versions
KR920002329B1 (ko
Inventor
다까까즈 모리따
다다시 이소
요우이찌 가와시마
미쓰시 히끼다
Original Assignee
미다 이다루
산뗑 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미다 이다루, 산뗑 세이야꾸 가부시끼가이샤 filed Critical 미다 이다루
Publication of KR900700103A publication Critical patent/KR900700103A/ko
Application granted granted Critical
Publication of KR920002329B1 publication Critical patent/KR920002329B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음

Description

항-알레르기성 점안제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 구조식[Ⅰ]의 화합물 또는 그의 염을 주성분으로 함유하는 항-알레르기성 점암제.
  2. 제1항에 있어서, 염이 캄륨임인 전점안제.
  3. 제2항에 있어서, 투여 제형이 점안액인 점안제.
  4. 제3항에 있어서, 인산 수소 이나트륨 및 인산 이수소나트륨이 첨가조제된 것을 특징으로 하는 점안액.
  5. 제3항에 있어서, 인산 수소 이나트륨 및 인산 이수소캄륨이 첨가조제된 것을 특징으로 하는 점안액.
  6. 제3항에 있어서, 붕산 및 붕산 나트륨 또는 붕산 및 모노에탄올 아민이 첨가 조제된 것을 특징으로 하는 점안액.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890701510A 1987-12-25 1988-12-23 항-알레르기성 점안제 KR920002329B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP62-331025 1987-12-25
JP331025/87 1987-12-25
JP33102587 1987-12-25
PCT/JP1988/001296 WO1989006130A1 (en) 1987-12-25 1988-12-23 Antiallergic eye drop

Publications (2)

Publication Number Publication Date
KR900700103A true KR900700103A (ko) 1990-08-11
KR920002329B1 KR920002329B1 (ko) 1992-03-21

Family

ID=18238980

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890701510A KR920002329B1 (ko) 1987-12-25 1988-12-23 항-알레르기성 점안제

Country Status (8)

Country Link
US (1) US5034230A (ko)
EP (1) EP0348527B1 (ko)
JP (1) JPH0662417B2 (ko)
KR (1) KR920002329B1 (ko)
AU (1) AU610979B2 (ko)
DE (1) DE3882042T2 (ko)
DK (1) DK418889A (ko)
WO (1) WO1989006130A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2504788B2 (ja) * 1987-11-10 1996-06-05 東京田辺製薬株式会社 ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤
US5126127A (en) * 1991-07-16 1992-06-30 Euroceltique, S.A. Stabilized PVP-I solutions
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
EP0948357B1 (en) * 1996-12-13 2002-06-12 Alcon Laboratories, Inc. Use of low molecular weight amino alcohols in ophthalmic compositions
AUPQ077199A0 (en) * 1999-06-03 1999-06-24 Fremantle Heart Institute Pty Ltd A method using potassium dihydrogen phosphate to reduce calcification of tissue
WO2002022131A1 (fr) * 2000-09-13 2002-03-21 Santen Pharmaceutical Co., Ltd. Collyre
US8277831B2 (en) * 2004-02-17 2012-10-02 Advanced Technologies And Regenerative Medicine, Llc. Drug-enhanced adhesion prevention
DK1906916T3 (da) * 2005-05-10 2009-01-19 Alcon Inc Oftalmisk suspension, der omfatter et oftalmisk lægemiddel, en poloxamin og et tonicitetsregulerende glycolbaseret middel, anvendelse af sammensætningen til fremstilling af et medikament til behandling af oftalmiske lidelser
TW200812575A (en) * 2006-04-28 2008-03-16 Alcon Inc Formulations containing amide derivatives of carboxylic acid NSAIDs for topical administration to the eye

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
JPS57171914A (en) * 1981-04-17 1982-10-22 Tokai Daigaku Antiallergic eye drop
JPS6050197A (ja) * 1983-08-30 1985-03-19 Mazda Motor Corp 部分電着塗装方法
JP2504788B2 (ja) * 1987-11-10 1996-06-05 東京田辺製薬株式会社 ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤

Also Published As

Publication number Publication date
DE3882042T2 (de) 1993-09-30
WO1989006130A1 (en) 1989-07-13
EP0348527B1 (en) 1993-06-23
EP0348527A1 (en) 1990-01-03
JPH01250321A (ja) 1989-10-05
JPH0662417B2 (ja) 1994-08-17
DE3882042D1 (de) 1993-07-29
AU610979B2 (en) 1991-05-30
US5034230A (en) 1991-07-23
DK418889D0 (da) 1989-08-24
DK418889A (da) 1989-08-24
KR920002329B1 (ko) 1992-03-21
AU2905689A (en) 1989-08-01
EP0348527A4 (en) 1991-08-07

Similar Documents

Publication Publication Date Title
KR860004060A (ko) 티에닐 축합 피라졸 유도체의 제조방법
FI875059A (fi) Foereningar.
KR840008014A (ko) 오메프라졸염의 제조방법
KR840004040A (ko) 수경성 시멘트 조성물
KR850007597A (ko) 항균제의 제법
KR830005394A (ko) 금속 탈거 조성물
KR940021059A (ko) 지질 대사 개선제
KR900700103A (ko) 항-알레르기성 점안제
KR860700250A (ko) 신규 아미딘 화합물
AR241022A2 (es) "fosfatidos de eteres de glicerina y procedimiento para su preparacion"
KR830005325A (ko) 수용성 화학 발광 시스템
KR850006191A (ko) 티오시아노 피리미딘 유도체의 제조방법
KR850001663A (ko) 살충 및 응애류 박멸제 조성물
KR840006238A (ko) 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법
KR830005188A (ko) 혈당강하성 구아닐 아미딘의 제조방법
AR241215A1 (es) Composiciones herbicidas.
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
KR840001144A (ko) 5(6)-페닐설포닐옥시-벤즈이미다졸 유도체의 제조방법
FR2382901A1 (ko)
KR890009876A (ko) 9-아실아미노- 테트라히드로아크리딘 유도체 및 그 유도체를 활성성분으로 포함하는 기억력 촉진제
KR860004021A (ko) 에틸렌이민 유도체의 제조방법
KR910011768A (ko) 파라위치가 치환된 6-브로모-2-시아노벤젠아민의 제조방법
KR830001236A (ko) 4(5)-하이드록시메틸 5(4)-저급알킬이미다졸류의 제조방법
KR850005839A (ko) 에르고트 유도체의 제조방법
KR830007532A (ko) 치환된 나프토산 우레이드 화합물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20080310

Year of fee payment: 17

EXPY Expiration of term